ELAN
Price
$18.43
Change
+$0.96 (+5.50%)
Updated
Sep 5 closing price
Capitalization
9.16B
66 days until earnings call
SCYX
Price
$0.89
Change
+$0.02 (+2.30%)
Updated
Sep 5 closing price
Capitalization
37.31M
60 days until earnings call
Interact to see
Advertisement

ELAN vs SCYX

Header iconELAN vs SCYX Comparison
Open Charts ELAN vs SCYXBanner chart's image
Elanco Animal Health
Price$18.43
Change+$0.96 (+5.50%)
Volume$6.92M
Capitalization9.16B
SCYNEXIS
Price$0.89
Change+$0.02 (+2.30%)
Volume$191.49K
Capitalization37.31M
ELAN vs SCYX Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. SCYX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and SCYX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ELAN: $18.43 vs. SCYX: $0.89)
Brand notoriety: ELAN: Notable vs. SCYX: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ELAN: 91% vs. SCYX: 109%
Market capitalization -- ELAN: $9.16B vs. SCYX: $37.31M
ELAN [@Pharmaceuticals: Generic] is valued at $9.16B. SCYX’s [@Pharmaceuticals: Generic] market capitalization is $37.31M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whileSCYX’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • SCYX’s FA Score: 0 green, 5 red.
According to our system of comparison, SCYX is a better buy in the long-term than ELAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 5 TA indicator(s) are bullish while SCYX’s TA Score has 6 bullish TA indicator(s).

  • ELAN’s TA Score: 5 bullish, 4 bearish.
  • SCYX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SCYX is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Generic) experienced а +0.44% price change this week, while SCYX (@Pharmaceuticals: Generic) price change was +7.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

SCYX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($9.16B) has a higher market cap than SCYX($37.3M). ELAN has higher P/E ratio than SCYX: ELAN (20.94) vs SCYX (0.91). ELAN YTD gains are higher at: 52.188 vs. SCYX (-26.446). ELAN has higher annual earnings (EBITDA): 1.45B vs. SCYX (-19.29M). ELAN has more cash in the bank: 539M vs. SCYX (44.8M). SCYX has less debt than ELAN: SCYX (2.39M) vs ELAN (4.21B). ELAN has higher revenues than SCYX: ELAN (4.48B) vs SCYX (3.26M).
ELANSCYXELAN / SCYX
Capitalization9.16B37.3M24,547%
EBITDA1.45B-19.29M-7,511%
Gain YTD52.188-26.446-197%
P/E Ratio20.940.912,314%
Revenue4.48B3.26M137,673%
Total Cash539M44.8M1,203%
Total Debt4.21B2.39M176,183%
FUNDAMENTALS RATINGS
ELAN vs SCYX: Fundamental Ratings
ELAN
SCYX
OUTLOOK RATING
1..100
5720
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7997
PRICE GROWTH RATING
1..100
3956
P/E GROWTH RATING
1..100
9198
SEASONALITY SCORE
1..100
2920

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCYX's Valuation (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for ELAN (93) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew somewhat faster than ELAN’s over the last 12 months.

SCYX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that SCYX’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's SMR Rating (79) in the Agricultural Commodities Or Milling industry is in the same range as SCYX (97) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to SCYX’s over the last 12 months.

ELAN's Price Growth Rating (39) in the Agricultural Commodities Or Milling industry is in the same range as SCYX (56) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to SCYX’s over the last 12 months.

ELAN's P/E Growth Rating (91) in the Agricultural Commodities Or Milling industry is in the same range as SCYX (98) in the Pharmaceuticals Other industry. This means that ELAN’s stock grew similarly to SCYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANSCYX
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
60%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
74%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICCX17.62N/A
N/A
Lord Abbett International Equity C
VTMGX18.86N/A
N/A
Vanguard Developed Markets Index Admiral
ISJBX19.83N/A
N/A
Voya US Stock Index Port S
CFXRX14.93N/A
N/A
Columbia Flexible Capital Income Inst2
RMBBX16.80N/A
N/A
RMB Small Cap I

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and AKAN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and AKAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+2.43%
AKAN - SCYX
31%
Poorly correlated
-2.54%
ELAN - SCYX
30%
Poorly correlated
+5.50%
AQST - SCYX
30%
Poorly correlated
+7.11%
SIGA - SCYX
29%
Poorly correlated
-0.82%
ACET - SCYX
27%
Poorly correlated
+1.00%
More